The other option is to proceed with Nasdaq, within 3 mths + 30 days extension ( after AGM 24April19):
Double the number of issued shares from 100m to 200m (ADS frm 15m to 30m, x70, at U15c to 7.5c, due to mkt conditions), raising Us15m.
That surley will make us ASX shh very happy, esp hc, and may get usa investors to buy in.
Will they?
You need to be pragmatic (flexible) to operate any business and cope with adversity.
In 1,2,3 years time, we can judge whether Gmed is a success story and Yacov is hero.
Now he is zero in many eyes.
- Forums
- ASX - By Stock
- GMV
- Ann: US Listing Update
Ann: US Listing Update, page-26
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online